Trial Profile
Study of Chidamide combined decitabine and etoposide in treating refractory and relapsed adult AML
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Etoposide (Primary) ; Tucidinostat (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 26 Mar 2018 New trial record